Can lipitor cause any side effects with allergy medication?

Can Lipitor interact with allergy medication?

Lipitor (atorvastatin) can interact with some allergy medications. For instance, antihistamines such as cetirizine,非处方抗组胺药 cetirizine, cetirizine, and fexofenadine sometimes require careful use alongside statins like Lipitor because muscle-related side effects may increase. Muscle pain and weakness are already common concerns for people taking Lipitor alone. When combined with certain antihistamines, the risk of those symptoms or more serious muscle damage may rise.

How common are these interactions?

These interactions are rare but possible. The main risk comes from shared pathways in the liver that both drugs use to break down. When the Statin side effect profile is amplified through competition for liver enzymes, muscle-related symptoms can appear. [1]

Why are companies challenging this patent?

Patent disputes around Lipitor have occurred since its basic composition patent expired in 2011. Companies producing generics have challenging the remaining formulation patents and method-of-use patents to bring affordable alternatives into the market. Companies such as Ranbaxy and Watson have successfully overturned some of off- Lipitor's remaining patents through litigation. [2]

When does exclusivity expire?

Lipitor's exclusivity expired long ago. The Haifa Israel based Ranbaxy company was the first to launch a generic version under an exclusive marketing period granted by the FDA. The generic is now widely available at much lower prices than the original branded version. [3]

What side effects are patients asking about?

Patients report muscle pain, weakness, and liver enzyme elevations on Lipitor. Patients who also take allergy medications are extra concerned when they enter any new medication into their medication list. When combined with certain antihistamines, the risk of muscle-related symptoms or more serious muscle damage may rise. [4]

Can biosimilars enter before patent expiry?

Biosimilars of Lipitor are not possible because Lipitor is a small-molecule drug, not a biologics. Generics are far more available and entry is regulated under Hatch-Waxman Act. Generics can enter under exclusivity periods granted through the FDA.